Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, July 28 2014 4:32am ET - U.S. Markets open in 4 hours and 58 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drugs - Generic News
Latest News
Monday, Jul 28, 2014
·Rumored Danone Medical Food Sale To Hospira Would End Ambition
at Forbes.com - 6 minutes ago
·Danone Shares Rise Amid Medical-Nutrition Unit Sale Speculation
at Bloomberg - 1 hour, 7 minutes ago
Sunday, Jul 27, 2014
·Hospira and Danone in Talks on $5 Billion Inversion Deal
at The New York Times - Sun 9:26 pm ET
·PRESS DIGEST- Financial Times - July 28
Reuters - Sun 9:08 pm ET
·Danone Said in Talks to Sell Its Medical Unit to Hospira
at Bloomberg - Sun 7:33 pm ET
·Danone in talks to sell medical nutrition unit to Hospira - FT
Reuters - Sun 2:10 pm ET
Friday, Jul 25, 2014
·Activis Shares Languish Post-Forest Deal
- Fri Jul 25
·[video] Tax inversion debate: Can Congress fix it?
at CNBC - Fri Jul 25
·[video] Greenlight's Einhorn: Mallinckrodt 'attractive short candidate'
at CNBC - Fri Jul 25
·Questcor (QCOR) Misses on Q2 Earnings, Beats on Revenues
Zacks.com - Fri Jul 25
·UPDATE: Bank Of America Downgrades Sagent Pharmaceuticals On Potential Near-Term Volatility
- Fri Jul 25
·MYOS Corporation Extends Manufacturing and Supply Agreement for Fortetropin
Marketwire - Fri Jul 25
·Galectin Therapeutics to Host Webcast to Discuss Findings From Cohort 2 of Phase 1 Clinical Trial of GR-MD-02 in Fatty Liver Disease With Advanced Fibrosis
GlobeNewswire - Fri Jul 25
·Mylan downgraded to Neutral from Buy at Citigroup
- Fri Jul 25
Thursday, Jul 24, 2014
·Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration
PR Newswire - Thu Jul 24
·Did Congress prescribe Obamacare a 'poison pill?'
at CNBC - Thu Jul 24
·Actelion Beats on Q2 Earnings and Sales, Revises View
Zacks.com - Thu Jul 24
·Obama: Companies that avoid taxes are renouncing citizenship
at MarketWatch - Thu Jul 24
·The Best Health Care Stock To Own Right Now
- Thu Jul 24
·Questcor Reports Record Second Quarter Financial Results
PR Newswire - Thu Jul 24
More Latest News...
Sponsor Results
Professional Statistician
1-on-1 Collaboration for your Project, Research, or Dissertation
www.OmegaStatistics.com
Clinical Study Start-up
Accelerate clinical trial start-up, site selection, and recruitment.
www.ePharmaSolutions.com
Industry News & Insights
Learn more about Industry News from the CSG Newsroom.
Newsroom.ChainStoreGuide.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?